SCHEMBL26288583

SCHEMBL26288583

CCCc1cnc(SCC(=O)O)[nH]c1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.53
ALDH1A1 P00352 3/20 0.51
ATM Q13315 1/20 0.51
KDM6B O15054 6/20 0.49
KDM4A O75164 6/20 0.49
KDM4D Q6B0I6 6/20 0.49
HIF1AN Q9NWT6 6/20 0.49
KDM2A Q9Y2K7 6/20 0.49
KDM3B Q7LBC6 5/20 0.49
KDM5B Q9UGL1 5/20 0.49
KDM4E B2RXH2 2/20 0.46
USP2 O75604 1/20 0.44
POLB P06746 1/20 0.44
TSHR P16473 1/20 0.44
KMT2A Q03164 1/20 0.42
PLA2G7 Q13093 2/20 0.42
MAPT P10636 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15925206 0.73 KMT2A (0.50) LMNAALDH1A1KDM6BKDM4AKDM4D
SCHEMBL3545647 0.73 PLA2G7 (0.67) LMNAALDH1A1KDM6BKDM4AKDM4D
SCHEMBL23542344 0.71 ALDH1A1 (0.50) LMNAALDH1A1ATMKDM4EUSP2
SCHEMBL25407708 0.70 ALDH1A1 (0.66) LMNAALDH1A1ATMKDM4EUSP2
SCHEMBL10980944 0.70 KDM6B (0.47) LMNAALDH1A1KDM6BKDM4AKDM4D
SCHEMBL20511270 0.69 ALDH1A1 (0.82) LMNAALDH1A1KDM4ETSHRKMT2A
SCHEMBL25408513 0.68 PDE10A (0.35) ALDH1A1KDM4ETSHR
SCHEMBL11421113 0.68 KDM6B (0.53) LMNAKDM6BKDM4AKDM4DHIF1AN
SCHEMBL10734964 0.68 KDM6B (0.46) LMNAALDH1A1ATMKDM6BKDM4A
SCHEMBL22042833 0.67 PDE9A (0.52) ALDH1A1POLBTSHRKMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230279008-A1 PTGR2 INHIBITORS AND THEIR USE NATIONAL TAIWAN UNIVERSITY (TW) 2023-09-07 US disclosed
US-20230279008-A1 PTGR2 INHIBITORS AND THEIR USE NATIONAL TAIWAN UNIVERSITY (TW) 2023-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230279008-A1 PTGR2 INHIBITORS AND THEIR USE PTGFR, PTGIR, PTGDR2 LMNA 3834/4885ALDH1A1 1177/4885ATM 3674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.